Interleukin 28 B (IL28B) Gene Variation Analysis
Chronic hepatitis C virus infection is still a major cause for developing cirrhosis and hepatocellular carcinoma which often results in liver failure and thus in liver transplantation. Worldwide, 170 million people are infected with the hepatitis C virus (HCV), and it has become the most common cause of liver-related death in the United States.
While up to 80% of the genotype 2 and 3 infected patients can be cured using the standard of care treatment, the response rate is only 40–50% in genotype 1 infections.
Therapeutic treatment for HCV depends on both viral and host factors. For example, HCV genotype is an important viral determinant of response: patients infected with type 1 or 4 have lower sustained virological response (SVR) rates than those infected with type 2 or 3. It has been shown that the major difference in response to therapy is caused by gene variation on host responses and specifically in Interleukin 28 B (IL28B).
The most common gene variation in IL28B is the single nucleotide polymorphism (SNP) IL28B rs12979860. Based on this gene variation or SNP, three genotypes are seen: CC, CT, and TT. The frequency of these alleles vary widely across racial and ethnic groups, with the rs12979860 CC genotype being present in about 37% of Caucasian individuals, 14% of African American individuals and 29% of Hispanic individuals. The C/C genotype of interleukin 28B (IL28B) was shown to be associated with a better SVR then C/T and T/T genotypes. SNPs near the IL28B region are the strongest baseline predictors of a SVR to pegylated interferon (PegIFN) and ribavirin (Rbv) in patients with hepatitis C virus (HCV) genotype 1 infection.
The IL28B mutation analysis test is used to determine the rs12979860 genotype to help predict therapeutic response in HCV-infected patients who are being considered for treatment with pegylated interferon-α/ribavirin or other available anti HVC therapy.
- Monitor HCV infection treatment response and therapy management
- Predicting HCV disease outcome
IL 28B CC
Three possible genotypes: CC, CT, and TT
Whole blood (EDTA). Buccal swab,
Stability
- Ambient: 3-5 days
- Refrigerated: 5-7 days
- Frozen: 30 days
- Hepatology. 2012 Jan;55(1):20-9. doi: 10.1002/hep.24623. [PMID: 21898478]
- J Hepatol. 2001 Sep;35(3):421-30. [PMID: 11592607]
- Hepatology. 2009 Jul;50(1):323. [PMID: 19554545]
- Clin Infect Dis. 2011 Apr 1;52(7):889-900. [PMID: 21427396]
- J Hepatol. 2011 Mar;54(3):415-21. [PMID: 21112657]
- Gastroenterol Clin Biol. 2010 Nov;34(11):587-9. [PMID: 20889274]
- Gastroenterology. 2010 Sep;139(3):821-7, 827. [PMID: 20621700]
- Rom J Intern Med. 2011;49(2):99-104. [PMID: 22303600]